Journal article
Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice
- Abstract:
- A 'Treat to Target' (T2T) approach has been proposed for ulcerative colitis (UC), with a target of combined clinical and endoscopic remission. The aim of the study was evaluate the extent to which proposed targets are achieved in real-world care, along with clinician perceptions and potential challenges.A multicentre, retrospective, cross-sectional review of patients with UC attending outpatient services in South Australia was conducted. Clinical and objective assessment of disease activity (endoscopy, histology, and/or biomarkers) was recorded. A survey evaluated Gastroenterologists' perceptions of T2T in UC. Statistical analysis included logistic regression and Fisher's exact tests.Of 246 patients with UC, 61% were in clinical remission (normal bowel habit and no rectal bleeding), 35% in clinical and endoscopic remission (Mayo endoscopic sub-score ≤1), and 16% in concordant clinical, endoscopic and histological (Truelove and Richards' Index) remission. Rather than disease-related factors (extent/activity), clinician-related factors dominated outcome. Hospital location and the choice of therapy predicted combined clinical and endoscopic remission (OR 3.6, 95% CI 1.6-8.7, p<0.001; OR 3.3, 95% CI 1.1-12.5, p=0.04, respectively). Clinicians used C-reactive protein (CRP) more often than endoscopy as a biomarker for disease activity (75% vs. 47%, p<0.001). In the survey, 45/61 Gastroenterologists responded, with significant disparity between clinician estimates of targets achieved in practice and real-world data (p<0.001 for clinical and endoscopic remission).Most patients with UC do not achieve composite clinical and endoscopic remission in 'real-world' practice. Clinician uptake of proposed 'Treat to Target' guidelines is a challenge to their implementation.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.1111/jgh.13923
Authors
- Publisher:
- Wiley
- Journal:
- Journal of Gastroenterology and Hepatology More from this journal
- Volume:
- 33
- Issue:
- 3
- Pages:
- 599-607
- Publication date:
- 2017-08-14
- Acceptance date:
- 2017-08-07
- DOI:
- EISSN:
-
1440-1746
- ISSN:
-
0815-9319
- Pmid:
-
28806471
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:724107
- UUID:
-
uuid:03002e46-5c48-425d-b079-309e55f7dcd3
- Local pid:
-
pubs:724107
- Source identifiers:
-
724107
- Deposit date:
-
2017-08-25
- ARK identifier:
Terms of use
- Copyright holder:
- © 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd
- Copyright date:
- 2017
- Notes:
- This is the author accepted manuscript following peer review version of the article. The final version is available online from Wiley at: 10.1111/jgh.13923
If you are the owner of this record, you can report an update to it here: Report update to this record